Nabumetone Tablet
Product Images NDC 50228-466

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 50228-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

This appears to be a medication label for Nabumetone tablets, with each tablet containing 500mg of the active ingredient. The label also includes details on dosage and storage instructions, as well as the name and address of the manufacturer, "SciGen".*

FDA Label Image

Container2 (Container2)

The text appears to be a label of medication for Nabumetone tablets, with each tablet containing 500 mg of the drug. The label provides information on the usual dosage, storage instructions, and precautions to be taken while using the medication. It also mentions the name of the manufacturer as SciGen.*

FDA Label Image

Container2 (Container3)

Each tablet contains nabumetone USP, 750 mg. The usual dosage is to store at a controlled room temperature between 20°C to 25°C (68°F to rhésasensss). Dispense in a light-resistant container as defined in the USP. An accompanying medication guide should be given to each patient and must be kept out of the reach of children. The product is manufactured by Actavis Pharma, Inc. of Hauppauge, NY 11768.*

FDA Label Image

Container2 (Container4)

This is a medication label for Nabumetone tablets. Each tablet contains 750mg of nabumetone USP. The usual dosage is to be determined by the prescribing information. The tablet must be stored at 20°C to 25°C but excursions are allowed between 15°C to 30°C. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The manufacturer is ScieGen Pharmaceuticas, Inc. with the NDC code 50228-466-05. This is a prescription medication and patients should receive the accompanying medication guide.*

FDA Label Image

Figure1 (Figure1)

This is a chart showing the plasma concentrations of the active metabolite (BMNA) of Nabumetone at steady state, following once-daily dosing of either 1000mg or 2000mg. There were 31 participants in the 1000mg group and 12 in the 2000mg group. The chart includes time in hours on the X-axis and plasma concentrations of BMNA on the Y-axis. There is no further information available.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.